About Immuno Cancer Biotherapeutics
Immuno Cancer Biotherapeutics is developing polyclonal antibody based therapies to target and overcome cancer heterogeneity and resistance.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Canton, United States
Tracked Since
Oct 17, 2026
Web & Domain Identity
Official Website
icbiothera.com
Domain Registered Date
Jul 1, 2024
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Seed announced
- Milestone
Website domain registered
icbiothera.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Immuno Cancer Biotherapeutics.
Funding History
Seed equity
· Oct 15, 2026
Undisclosed
Founders & Leadership
James Robl
Co-founder, President and CSO
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026